Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo

Invest New Drugs. 2022 Apr;40(2):274-289. doi: 10.1007/s10637-021-01204-4. Epub 2022 Jan 4.

Abstract

Background One of the main challenges in the clinical treatment of lung cancer is resistance to chemotherapeutic drugs. P-glycoprotein (P-gp)-mediated drug resistance is the main obstacle to successfully implementing microtubule-targeted tumor chemotherapy. Purpose In this study, we explored the effect of Ad-hTERTp-E1a-Apoptin (Ad-VT) on drug-resistant cell lines and the molecular mechanism by which Ad-VT combined with chemotherapy affects drug-resistant cells and parental cells. Methods In vitro, cell proliferation, colony formation, resistance index (RI), apoptosis and autophagy assays were performed. Protein expression was analyzed by Western blotting. Finally, a xenograft tumor model in nude mice was used to detect tumor growth and evaluate histological characteristics. Results Our results showed that Ad-VT had an obvious killing effect on A549, A549/GEM and A549/Paclitaxel cancer cells, and the sensitivity of drug-resistant cell lines to Ad-VT was significantly higher than that of parental A549 cells. Compared with A549 cells, A549/GEM and A549/Paclitaxel cells had higher autophagy levels and higher viral replication ability. Ad-VT decreased the levels of p-PI3k, p-Akt and p-mTOR and the expression of P-gp. In vivo, Ad-VT combined with chemotherapy can effectively inhibit the growth of chemotherapy-resistant tumors and prolong the survival of mice. Conclusions Thus, the combination of Ad-VT and chemotherapeutic drugs will be a promising strategy to overcome chemoresistance.

Keywords: Apoptosis; Autophagy; Lung cancer cells; Oncolytic virus; P-gp.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung* / drug therapy
  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Deoxycytidine / analogs & derivatives
  • Drug Resistance, Neoplasm
  • Gemcitabine
  • Humans
  • Lung Neoplasms* / pathology
  • Mice
  • Mice, Nude
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Xenograft Model Antitumor Assays

Substances

  • Deoxycytidine
  • Paclitaxel
  • Gemcitabine